Seasonal gaps in measles vaccination coverage in Madagascar.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
24 04 2019
Historique:
received: 15 08 2018
revised: 17 02 2019
accepted: 20 02 2019
pubmed: 4 4 2019
medline: 17 9 2020
entrez: 4 4 2019
Statut: ppublish

Résumé

Measles elimination depends on the successful deployment of measles containing vaccine. Vaccination programs often depend on a combination of routine and non-routine services, including supplementary immunization activities (SIAs) and vaccination weeks (VWs), that both aim to vaccinate all eligible children regardless of vaccination history or natural infection. Madagascar has used a combination of these activities to improve measles coverage. However, ongoing massive measles outbreak suggests that the country was in a "honeymoon" period and that coverage achieved needs to be re-evaluated. Although healthcare access is expected to vary seasonally in low resources settings, little evidence exists to quantify temporal fluctuations in routine vaccination, and interactions with other immunization activities. We used three data sources: national administrative data on measles vaccine delivery from 2013 to 2016, digitized vaccination cards from 49 health centers in 6 health districts, and a survey of health workers. Data were analyzed using linear regressions, analysis of variance, and t-tests. From 2013 to 2016, the footprint of SIAs and VWs is apparent, with more doses distributed during the relevant timeframes. Routine vaccination decreases in subsequent months, suggesting that additional activities may be interfering with routine services. The majority of missed vaccination opportunities occur during the rainy season. Health facility organization and shortage of vaccine contributed to vaccination gaps. Children born in June were the least likely to be vaccinated on time. Evidence that routine vaccination coverage varies over the year and is diminished by other activities suggests that maintaining routine vaccination during SIAs and VWs is a key direction for strengthening immunization programs, ensuring population immunity and avoiding future outbreaks. Wellcome Trust Fund, Burroughs Wellcome Fund, Gates Foundation, National Institutes of Health.

Identifiants

pubmed: 30940486
pii: S0264-410X(19)30276-2
doi: 10.1016/j.vaccine.2019.02.069
pmc: PMC6466641
pii:
doi:

Substances chimiques

Measles Vaccine 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2511-2519

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NLM NIH HHS
ID : DP2 LM013102
Pays : United States
Organisme : NICHD NIH HHS
ID : P2C HD047879
Pays : United States
Organisme : Wellcome Trust
ID : 106866/Z/15/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Vaccine. 2014 Jun 12;32(28):3533-9
pubmed: 24814558
Clin Infect Dis. 2014 Aug 15;59(4):484-92
pubmed: 24829213
Health Policy Plan. 2016 Nov;31(9):1225-31
pubmed: 27175031
PLoS One. 2012;7(6):e38370
pubmed: 22675551
Vaccine. 2017 Sep 5;35(37):4836-4839
pubmed: 28797728
Stat Med. 2007 Jul 10;26(15):3018-45
pubmed: 17177166
Lancet. 1995 Feb 4;345(8945):272
pubmed: 7837860
Glob Health Action. 2015 Oct 01;8:29003
pubmed: 26434691
Vaccine. 2012 Feb 21;30(9):1594-600
pubmed: 22230581
Vaccine. 2019 Jan 7;37(2):219-222
pubmed: 28760612
Vaccine. 2016 Jun 17;34(29):3335-41
pubmed: 27195759
J Epidemiol Community Health. 2013 Nov 1;67(11):947-52
pubmed: 23975755
Int J Health Geogr. 2012 Jun 27;11:24
pubmed: 22737990
J Infect Dis. 2011 Jul;204 Suppl 1:S78-81
pubmed: 21666217
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
Am J Epidemiol. 2018 Oct 1;187(10):2219-2226
pubmed: 29878051
Soc Sci Med. 2003 Nov;57(10):1807-19
pubmed: 14499507
Epidemiol Infect. 2015 May;143(7):1457-66
pubmed: 25119237
J Infect Dis. 1994 Nov;170 Suppl 1:S32-41
pubmed: 7930752
Disabil Rehabil. 2019 Mar;41(6):683-690
pubmed: 29172751

Auteurs

K Mensah (K)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA. Electronic address: kmensah@princeton.edu.

J M Heraud (JM)

Virology Unit, Institut Pasteur de Madagascar, Antananarivo, Madagascar.

S Takahashi (S)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.

A K Winter (AK)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA.

C J E Metcalf (CJE)

Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ, USA; Woodrow Wilson School of Public Affairs, Princeton University, Princeton, NJ, USA.

A Wesolowski (A)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: awesolowski@jhu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH